Reference health

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus

https://doi.org/10.1016/j.chom.2015.06.009
CiteStamped reference-health badge
1 of 38 checkable references need attention · checked 2026-07-22

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

marked retracted — notice via Crossref, record curated by Retraction Watch10.1073/pnas.1317350111
RETRACTED: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
The 37 checked references that resolve
resolves10.1016/j.virol.2007.09.028
Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein
resolves10.1016/j.vaccine.2013.05.059
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
resolves10.1086/600381
Prophylaxis and Therapy for Chikungunya Virus Infection
resolves10.1099/0022-1317-67-2-377
Sindbis Virus-mediated Cell Fusion from Without Is a Two-step Event
resolves10.1128/JVI.01943-14
Exposure of Epitope Residues on the Outer Face of the Chikungunya Virus Envelope Trimer Determines Antibody Neutralizing Efficacy
resolves10.1093/infdis/jis674
Use of Human Monoclonal Antibodies to Treat Chikungunya Virus Infection
resolves10.1016/j.clim.2013.10.004
Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model
resolves10.1128/JVI.01926-14
Prime-Boost Immunization Strategies against Chikungunya Virus
resolves10.1128/JVI.02666-13
Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response
resolves10.1128/JVI.01388-13
Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site
resolves10.1128/JVI.01780-12
Longitudinal Analysis of the Human Antibody Response to Chikungunya Virus Infection: Implications for Serodiagnosis and Vaccine Development
resolves10.1002/emmm.201200213
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein
resolves10.1371/journal.pone.0095647
Unique Epitopes Recognized by Antibodies Induced in Chikungunya Virus-Infected Non-Human Primates: Implications for the Study of Immunopathology and Vaccine Development
resolves10.3390/v2040796
Alphavirus Entry and Membrane Fusion
resolves10.1128/JVI.02184-09
Naturally Occurring Human Monoclonal Antibodies Neutralize both 1918 and 2009 Pandemic Influenza A (H1N1) Viruses
resolves10.1128/JVI.00700-11
A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin
resolves10.4049/jimmunol.1101823
Epitope-Specific Human Influenza Antibody Repertoires Diversify by B Cell Intraclonal Sequence Divergence and Interclonal Convergence
resolves10.1128/JVI.07158-11
Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
resolves10.1371/journal.ppat.1002390
Chikungunya Virus Neutralization Antigens and Direct Cell-to-Cell Transmission Are Revealed by Human Antibody-Escape Mutants
resolves10.4049/jimmunol.1300304
An Essential Role of Antibodies in the Control of Chikungunya Virus Infection
resolves10.1016/j.virol.2014.05.038
Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release
resolves10.1371/journal.ppat.1003312
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
resolves10.1128/JVI.01032-14
Chikungunya Viruses That Escape Monoclonal Antibody Therapy Are Clinically Attenuated, Stable, and Not Purified in Mosquitoes
resolves10.1371/journal.pntd.0002137
Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study
resolves10.1371/journal.pntd.0002423
A Neutralizing Monoclonal Antibody Targeting the Acid-Sensitive Region in Chikungunya Virus E2 Protects from Disease
resolves10.1371/journal.pntd.0000389
Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period
resolves10.1128/JVI.06335-11
Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
resolves10.1128/mBio.00873-13
The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
resolves10.1093/infdis/jit119
Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics
resolves10.1128/JVI.00247-14
Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones
resolves10.1086/605496
Chikungunya Fever: An Epidemiological Review of a Re‐Emerging Infectious Disease
resolves10.7554/eLife.00435
Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization
resolves10.1128/JVI.02990-13
Stable, High-Level Expression of Reporter Proteins from Improved Alphavirus Expression Vectors To Track Replication and Dissemination during Encephalitic and Arthritogenic Disease
resolves10.1172/JCI69377
Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses
resolves10.1038/nature09555
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
resolves10.4049/jimmunol.1003139
Chikungunya Virus Envelope-Specific Human Monoclonal Antibodies with Broad Neutralization Potency
resolves10.1038/nature07231
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
The 2 references without a DOI — listed, not checked
no DOI — not checked10.1016/j.chom.2015.06.009_bib2
no DOI — not checked10.1016/j.chom.2015.06.009_bib3
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.chom.2015.06.009"><img src="https://citestamp.com/citestamped/10.1016/j.chom.2015.06.009/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.chom.2015.06.009/badge.svg)](https://citestamp.com/citestamped/10.1016/j.chom.2015.06.009)